ASCP Corner September 30, 2008

Are Nutritional Supplements Ready for Prime Time?

David Mischoulon, MD, PhD; Maurizio Fava, MD

J Clin Psychiatry 2008;69(9):1497-1498

Article Abstract

Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.

Over the past 20 years, there has been a surge of clinical trials examining the safety and efficacy of natural compounds for psychiatric indications. These studies have produced encouraging evidence for several putative antidepressants such as S-adenosyl-L-methionine (SAMe), St. John’s wort (SJW), the omega-3 fatty acids, and folic acid.

There are about 45 published randomized controlled trials(RCTs) of SAMe monotherapy against placebo or tricyclic antidepressants(TCAs).

Continue Reading...

Did you know members enjoy unlimited free PDF downloads as part of their subscription? Subscribe today for instant access to this article and our entire library in your preferred format. Alternatively, you can purchase the PDF of this article individually.

Subscribe Now

Already a member? Login

Purchase PDF for $40.00

Members enjoy free PDF downloads on all articles. Join today